CURRICULUM VITAE
2012, March
OVERVIEW INFORMATION
Name: MARHOUM EL FILALI Kamal
Date and birthplace: July 16 , 1958 in Casablanca, Morocco Sex: Male
Nationality: Moroccan Contact Information:
Business contact Personal details
Address: Faculté de Médecine Address: Résidence Mawlid 3, Appt C54 19, Rue Tarik Bnou Ziad Rue Abou Taour
20340 Casablanca, Morocco 20370 Casablanca, Morocco Tel: +212 5 22 48 20 66 Tel: +212 6 64 00 31 75
Fax: +212 5 22 20 43 33 Email: mefkamal@gmail.com Email: mefkamal@hotmail.com
Areas of expertise:
- Clinical experience in infectious diseases, particularly in care of HIV infected patients
- Quantification of antiretroviral drugs needs for HIV infected patients in Morocco
- HIV/AIDS prevention campaigns
- Evaluation of projects related to HIV/AIDS
- Education and training in the field of infectious diseases and HIV infection
Expertise related to HIV/AIDS - In Morocco:
• Collaboration with the National AIDS Program
• Commitment in the Moroccan experience of access to care and to antiretroviral therapy
• Involvement in many national campaigns of prevention
• In charge of HIV infection course in the Faculty of Medicine and Pharmacy of Casablanca
- At the international level :
• Collaboration as consultant with UNAIDS (Republic of Congo in 2001)
• Contribution to the development of an african consensus on antiretroviral therapy ( Dakar,
October 2000 )
• Collaboration as consultant with WHO-EMRO (Republic of Yemen in 2007)
• Collaboration as consultant with WHO-EMRO (Republic of Syria in 2009)
EDUCATION
1993 Certificate in Infected Patient Resuscitation Xavier Bichat University Paris, France
1993 Certificate in AIDS and retroviral diseases Xavier Bichat University, Paris, France
1993 Certificate ‘Résident Etranger du Collège de
Médecine des Hôpitaux de Paris’
Collège de Médecine des Hôpitaux de Paris, France
1989 Maghreban Certificate in Health Sciences
Pedagogy
Medical School, Casablanca, Morocco
1985 MD Medical School, Casablanca, Morocco
1976 – 1985 Medical School, Casablanca, Morocco
1976 Baccalaureate University of Bordeaux, France
1961 – 1976 Lycée Lyautey, Casablanca, Morocco
TRAINING
2010, October Antifungal preceptorship meeting. University of South Manchester, UK
2008, February Human Participants Protection Education for Research Teams
NIH, online course
2007, June Advanced Course on Security WHO, online course
2006, October GCP Training for investigators Roche, Casablanca, Morocco
2006, April Course on applied regression modelling University of Bristol and University of
Bern, Cape Town, South Africa
2005, July Course : Managing Procurement and Logistics of
HIV/AIDS Drugs and Related Supplies
World Bank Institute, Beirut, Lebanon
2002, July Training : Clinical studies monitoring Georges Pompidou European Hospital,
Paris, France
2001, March Atelier de mise à niveau des consultants
francophones
UNAIDS / WHO, Rabat, Morocco
2000, June The 2nd african workshop on antiretrovirals Dakar, Senegal
1997, May Symposium on HIV infection Mediterranean Society of Infectious and Parasitic Diseases, Cairo, Egypt
1996, March Course on Research Methodology Medical School, Casablanca, Morocco
1995, April Course on biostatistics Medical School, Casablanca, Morocco
1992 – 1993 Training : Intensive care Bichat-Claude Bernard Hospital, Paris,
France
1992, June Training : Digestive endoscopia Beaujon Hospital, Paris, France
1990, January Training : HIV infection care practice Bichat-Claude Bernard Hospital Paris,
France
WORKING EXPERIENCES
Permanent positions
Since 2011 Head of the Infectious Diseases Unit of Ibn Rochd University Hospital.
Since 2003 Member of the National Committee of Management of HIV infection (Ministry of Health)
Since 1997 Responsibility of ARVs quantification for the treatment of HIV infected patients in Morocco
Since 1997 In charge of HIV infection course in the Medical School of Casablanca
Since 1988 National Board member of ‘Association de Lutte Contre le Sida’
Since 1987 Physician in charge of management of HIV infection in the Infectious Diseases Unit of Ibn Rochd
University Hospital
Academic positions (Medical School of Casablanca)
1993 Professor of Infectious Diseases
1989 – 1993 Associate Professor 1986 – 1989 Assistant
1984 – 1986 Resident
INVOLVEMENT IN RESEARCH GRANTS
• 2002 – 2009 : Evaluation of Subcutaneous Proleukin® in a Randomized International Trial
(ESPRIT001), a randomized, open label, phase III, international study of subcutaneous recombinant interleukin-2 (Proleukin®) in patients with HIV-1 infection and CD4+ Cell Counts ≥ 300/mm3.
Site principal investigator: Hakima Himmich
The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 26 participants. Role in this research: Site co- investigator.
Research conducted by NIH
Financial support of NIH via Medical Research council in London Amount of money in the research grant: 103 664 GBP
• 2007 – 2011 : Study of Aldesleukin with and without Antiretroviral Therapy (STALWART :
ESPRIT002), a randomized, open-label, international study of subcutaneous recombinant interleukin-2 (Aldesleukin®) with and without concomitant antiretroviral therapy in patients with HIV-1 infection and CD4+ Cell Counts ≥ 300/mm3.
Site principal investigator: Hakima Himmich
The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 1 patient. Role in this research: Site co- investigator.
Research conducted by NIH
Financial support of NIH via Medical Research council in London Amount of money in the research grant: 3 162 GBP
• 2004 – 2007 : The SMART Study, a large, simple trial comparing the long-term clinical consequences
of two Strategies for Management of Anti-Retroviral Therapy (Protocol CPCRA 065), the drug
conservation strategy, a strategy aimed at conserving drugs through episodic use of antiretroviral treatment for the minimum time to maintain CD4+ cell count > 250 cells/mm3 versus the viral suppression strategy, a strategy aimed at suppressing viral load as much as possible, immediately following randomization and throughout follow up, irrespective of CD4+ cell count.
Site principal investigator: Hakima Himmich
The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 42 patients. Role in this research: Site investigator.
Research conducted by NIH
Financial support of NIH via Medical Research council in London Amount of money in the research grant: 307 382 USD
• 2010 - ongoing : Strategic Timing of AntiRetroviral Treatment (START), a randomized study to
determine whether immediate initiation of antiretroviral treatment (ART) is superior to deferral of ART until the CD4+ declines below 350 cells/mm3 in terms of morbidity and mortality in HIV-1 infected persons who are antiretroviral naïve with a CD4+ count above 500 cells/mm3.
The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has included 21 patients and the enrolment is ongoing .
Role in this research: site principal investigator. Research conducted by NIH
Financial support of NIH via Medical Research council in London
Amount of money in the research grant: 775 600 USD (if the goal of 50 patients is reached)
• 2003-2007 : The Antiretroviral Treatment in Lower Income Countries
(ART-LINC) Collaboration to define prognosis of HIV-infected patients treated with HAART in
resource-poor settings, to compare experiences between different settings, delivery modes, and types of monitoring and to compare prognosis in resource-limited settings with that observed in industrialized nations.
Principal investigators: François Dabis, Mathias Egger, Mauro Schechter
The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has participated with its cohort data.
Role in this research: clinic representative.
Research conducted by the University of Bern and the University of Bordeaux. Financial support of ANRS (France), CIHR (Canada) and NIH.
CONSULTATIONS AND PROGRAMMATIC EXPERIENCE
2011 Consultation on provider initiated HIV testing in
health care settings
Morocco Ministry of Health
2010 Consultation on HIV prophylaxis in case of sexual
violence
Morocco Ministry of Health
2006 Consultation on sharp waste management in hospital
(2nd phase) Morocco Ministry of Health
2004 Consultation on sharp waste management in hospital Morocco Ministry of Health
2003 Assessment and strengthening of referral centers for
HIV infection management
Morocco Ministry of Health
2001 Consultation on implementation of Access Initiative Republic of Congo UNAIDS
Since 2000 Coordinator of the education program for patients under ART Casablanca Morocco Infectious diseases unit/GSK foundation
2000 Contribution to the development of an African
consensus on ART
Dakar, Senegal
Since 1997 Consultation on ARVs procurement and supplying Morocco Ministry of Health
Since 1993 Collaboration with the National AIDS Program Morocco Ministry of Health
REGIONAL EXPERIENCE
March 2009 Syria : Consultation for the development of the GFATM proposal (WHO).
July 2007 Yemen : Consultation on ART for the NAP at ART sites of Sanaa and Aden (WHO).
2002 – 2007 Member of the steering group of Antiretroviral Therapy in Low Income Countries
(ART-LINC) collaboration
Since 1994 Morocco (Casablanca) : HIV Infection management
July 2001 Republic of Congo : Program Access of UNAIDS
1992 – 1993 France (Paris) : HIV infection management
1986 – 1991 Morocco (Casablanca) : Infectious diseases management
1984 – 1986 Morocco (Casablanca) : Internal medicine diseases management
PUBLICATIONS
1. Sodqi M, Marih L, Oulad Lahsen A, Bensghir R, Chakib A, Himmich H, Marhoum El Filali K. Causes de décès de 91 patients ayant une infection à VIH traités par des antirétroviraux. La Presse Médicale 2012, in press
2. Fane M, Oulad Lahsen A, Bakhatar A, Sodqi M, Marhoum El Filali K, Bahlaoui A, Chakib A. Aspergilose pulmonaire et infection à VIH (à propos de deux cas). Rev Pneumol Clin 2012, 68, 1 :36-9 3. Oulad Lahsen A, Rachidi T, Sodqi M, Abada R, Marhoum El Filali K. Paralysie faciale associée à la
leptospirose. Médecine et Maladies Infectieuses 2010; 40, 12 :716-717
4. Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Marhoum El Filali K, Ezzikouri S, Abidi O, Hassar M, Wakrim L. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve HIV1-infected individuals in Casablanca, Morocco. J Infect Dev Ctries 2009; 3(5):380-391
5. Kamal Marhoum El Filali, Hakima Himmich, Bloodstream infections. In : a guide to infection control
in hospital (fourth edition), R. Wenzel, G. Bearman, T. Brewer, J.P. Butzler (Eds). Brookline, 2008 ; 170-72.
6. Sandrine Loubière, Kamal Marhoum El Filali, Mustapha Sodqi, Anderson Loundou, Stéphane Luchini, Susan Cleary, Jean-Paul Moatti, Hakima Himmich. When to initiate highly active antiretroviral therapy in low resource settings : the Moroccan experience. Antiviral Therapy 2008 ; 13 : 241-51
7. Gaëlle Krikorian, Kamal Marhoum El Filali, Hakima Himmich. L’accès aux médicaments sous le nouveau régime de protection des brevets : cas du sida au Maroc. Knowledge Ecology Studies 2008 ; Vol.2 (Journal on-line : http://www.kestudies.org/)
8. ART-LINC Collaboration. Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol. 2005 Oct;34(5):979-86
9. Marih L, Sodqi M, Chakib A, Malmoussi M, Ouagari Z, Marhoum El Filali K, Himmich H. Kaposi cutané de forme tumorale: difficultés diagnostiques à propos d’un cas. Rev Maroc Med Santé 2005, 22, 1 : 44-47
10. Guide de la prise en charge de l’infection à VIH. Edité par le Ministère de la Santé, avec le soutien de l’OMS, sous la coordination du Pr Hakima Himmich, Rabat, 2004.
11. Malmoussi M, Zerouali K, Aajly L, Marhoum El Filali K, El Mdaghri N, Benbachir M, Himmich H. Méningite à méningocoque de l’adulte à propos de 117 cas. J Magh A Réa 2003, 43 : 262-5
12. Marih l, Sodqi M, Bensghir R, Marhoum El Filali K, Himmich H. Monitoring for efficacy of HAART in limited resource countries. Proceeding of International AIDS Conference, July 2002. 363-364. 13. Sodqi M, Marih L, Marhoum El Filali K, Himmich H. Infection with Mycobacterium tuberculosis
among HIV infected patients in Morocco. Proceedings of the XIV International AIDS Conference. July 2002. Barcelone.
14. Soussi-Abdallaoui M, El Kadioui-El Idrissi F, Chakib A, Marhoum El Filali K, Himmich H, Guessous-Idrissi N. Isospora belli au Maroc à propos de 4 nouveaux cas. Les Cahiers du Medecin 2002, 48 : 41-43.
15. Marhoum El Filali K, A Chakib, Himmich H. Accès aux antirétroviraux au Maroc. Bulletin S.M.S.M
1999, 1 : 17 – 21.
16. Marhoum El Filali K. Prise en charge d’un malade infecté par le VIH. Les cahiers du Médecin 1998 ;
11 : 25 – 27
17. Marhoum El Filali K. Prophylaxie de l’infection à VIH après une exposition accidentelle au sang. Les
cahiers du Médecin 1998 ; 11 : 28 – 29
18. Zahraoui M, Arssi M, Marhoum El Filali K, Chakib A, Himmich H. Tuberculose et infection par le VIH. Rev Maroc Med Santé 1992 , 14 ,1 : 7-12